HGH Fragment 176-191 CJC-1295 no DAC

Direct Anti Peptide supplies the HGH Fragment 176-191 CJC-1295 No DAC Blend as a high-purity research peptide formulated at ≥98% purity for qualified laboratory investigators. This dual-peptide vial contains HGH Fragment 176-191 at 1.7mg and CJC-1295 No DAC at 0.8mg, delivering a precisely measured 2.5mg total blend designed to support advanced in vitro and preclinical research. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

The HGH Fragment 176-191 CJC-1295 No DAC Blend is a targeted dual-peptide formulation available for sale at Direct Anti Peptide, developed to support researchers investigating growth hormone (GH) pathway modulation, fat metabolism dynamics, and lean mass preservation. By combining two complementary research compounds in a single vial, this blend streamlines experimental workflows and offers researchers a convenient, cost-effective tool for studying the synergistic interaction between a GH-releasing peptide and a selective GH fragment. Both components are manufactured to ≥98% purity, ensuring analytical-grade reliability for demanding research protocols.

Peptide Structure & Amino Acid Sequence

This blend incorporates two structurally distinct peptides. HGH Fragment 176-191 is a truncated analogue of the C-terminal region of human growth hormone, spanning amino acid positions 176 through 191. Its sequence is: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with a disulfide bridge that confers structural stability. This modification is understood to retain selective activity on adipose tissue metabolism while eliminating the broader anabolic signaling associated with full-length GH. CJC-1295 No DAC (also referenced as Modified GRF 1-29) is a 29-amino acid analogue of growth hormone-releasing hormone (GHRH), engineered with four amino acid substitutions to enhance receptor affinity and proteolytic resistance compared to native GHRH. Together, these two sequences represent a complementary pairing of interest to researchers exploring GH axis biology.

Chemical & Physical Characteristics

• Blend Composition: HGH Fragment 176-191 (1.7mg) + CJC-1295 No DAC (0.8mg)
• Total Vial Content: 2.5mg lyophilized blend
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffer systems under controlled laboratory conditions
• Molecular Classification: Synthetic peptide blend
• Purity: ≥98% (each component)

Purity & Analytical Verification (HPLC & MS)

Every batch of the HGH Fragment 176-191 CJC-1295 No DAC Blend produced for Direct Anti Peptide undergoes rigorous analytical testing prior to release. High-performance liquid chromatography (HPLC) is used to confirm purity at ≥98% for each individual peptide component. Mass spectrometry (MS) verification confirms molecular identity and rules out unwanted by-products or degradation fragments. Certificates of Analysis (CoA) reflecting these results are available upon request, providing full traceability for research documentation purposes.

Quality Control & Lyophilization Integrity

The blend is lyophilized under controlled freeze-drying conditions to preserve structural integrity and long-term stability. Lyophilization removes residual moisture to levels consistent with stable peptide storage, minimizing the risk of hydrolytic degradation during transit and storage. Each vial is sealed under inert conditions and subjected to quality control checks covering visual appearance, moisture content, and batch-to-batch consistency. This rigorous QC pipeline ensures that researchers receive a product that meets analytical expectations every time they order from Direct Anti Peptide.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for trained laboratory professionals operating within appropriately equipped research facilities. Standard laboratory personal protective equipment (PPE), including gloves, eye protection, and a lab coat, should be worn during all handling procedures. Researchers should consult applicable institutional safety guidelines and material safety data sheets (MSDS) before use. This peptide blend is not approved for any human or animal administration and must not be used outside of a controlled research setting.

Reconstitution, Packaging & Storage

The lyophilized blend should be reconstituted using sterile aqueous solutions appropriate for the specific research application, following validated laboratory protocols. Upon receipt, vials should be stored at −20°C in a frost-free freezer to maintain maximum stability. Once reconstituted, the solution should be stored at 4°C and used within a timeframe consistent with established peptide stability data. All storage and handling must comply with institutional biosafety and chemical handling regulations.

Intended Research Use & Market Positioning

This blend is positioned as a premium research tool for scientists investigating GH axis modulation, adipose tissue lipolysis, lean body mass preservation, and metabolic rate regulation in preclinical models. The combination of HGH Fragment 176-191 and CJC-1295 No DAC makes this vial particularly relevant for researchers seeking to study the coordinated effects of GH secretagogue stimulation alongside selective fat metabolism signaling. Direct Anti Peptide offers this blend for sale to verified research institutions, universities, and qualified independent laboratories.

Ordering, Availability & Fulfillment

The HGH Fragment 176-191 CJC-1295 No DAC Blend is available to buy online now through Direct Anti Peptide. Orders are processed promptly, with careful packaging designed to preserve lyophilized integrity during shipping. Bulk ordering options and twin-pack savings are available for qualifying research programs. Our fulfillment team ensures fast dispatch and reliable delivery to research facilities globally. Contact our support team for volume pricing, CoA requests, or order inquiries.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The HGH Fragment 176-191 CJC-1295 No DAC Blend is sold exclusively as a laboratory research reagent. Direct Anti Peptide makes no claims regarding therapeutic efficacy, safety for human consumption, or suitability for any application outside of controlled scientific research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the purchase, possession, and use of research peptides. This product must not be misused, reformulated, or redistributed for any non-research purpose.